Ligand Pharmaceuticals Incorporated (LGND) Insider Trading
- $5,339,328.39
- $218,460,059.45
- Nov. 27, 2024
- John L Higgins
| Trader Name | Date | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|---|
| Nov. 27, 2024 | Director | 2,406 | $123.65 | Sell | $297,501.90 | |
| Sept. 23, 2024 | Insider | 2,000 | $99.60 | Sell | $199,200.00 | |
| Sept. 23, 2024 | COO | 9,772 | $101.22 | Sell | $989,121.84 | |
| Sept. 20, 2024 | COO | 6,275 | $104.10 | Sell | $653,227.50 | |
| Sept. 20, 2024 | CFO | 1,275 | $103.94 | Sell | $132,523.50 | |
| Aug. 28, 2024 | Insider | 1,500 | $106.39 | Sell | $159,585.00 | |
| Aug. 26, 2024 | COO | 11,389 | $105.61 | Sell | $1,202,792.29 | |
| Aug. 22, 2024 | COO | 1,157 | $105.54 | Sell | $122,109.78 | |
| Aug. 9, 2024 | COO | 18,245 | $98.50 | Sell | $1,797,132.50 | |
| Aug. 8, 2024 | CEO | 2,500 | $97.39 | Buy | $243,475.00 | |
| May 17, 2024 | CFO | 5,156 | $86.66 | Sell | $446,818.96 | |
| May 15, 2024 | CFO | 5,873 | $86.01 | Sell | $505,136.73 | |
| May 13, 2024 | Insider | 3,440 | $84.54 | Sell | $290,817.60 | |
| May 9, 2024 | Insider | 10,000 | $83.04 | Sell | $830,400.00 | |
| March 5, 2024 | Director | 1,893 | $74.30 | Sell | $140,649.90 | |
| Feb. 28, 2024 | CFO | 140 | $88.46 | Sell | $12,384.40 | |
| Sept. 22, 2023 | CEO | 4,000 | $59.38 | Buy | $237,520.00 | |
| May 16, 2023 | Director | 4,444 | $77.20 | Sell | $343,076.80 | |
| May 10, 2023 | Director | 6,408 | $77.13 | Sell | $494,249.04 | |
| May 8, 2023 | Director | 6,408 | $76.56 | Sell | $490,596.48 | |
| March 24, 2023 | Insider | 300 | $69.92 | Sell | $20,976.00 | |
| Dec. 16, 2022 | Director | 10,000 | $61.87 | Sell | $618,700.00 | |
| Nov. 17, 2022 | CEO | 10,000 | $78.32 | Sell | $783,200.00 | |
| Nov. 9, 2022 | CFO | 1,696 | $75.64 | Sell | $128,285.44 | |
| Sept. 15, 2022 | CEO | 2,000 | $90.00 | Sell | $180,000.00 | |
| May 13, 2022 | COO | 2,500 | $82.76 | Buy | $206,900.00 | |
| Feb. 28, 2022 | Director | 908 | $102.62 | Sell | $93,178.96 | |
| Nov. 12, 2021 | CEO | 3,000 | $160.50 | Sell | $481,500.00 | |
| Nov. 11, 2021 | COO | 11,160 | $163.02 | Sell | $1,819,303.20 | |
| Aug. 4, 2021 | COO | 8,840 | $109.67 | Sell | $969,482.80 | |
| Feb. 10, 2021 | Director | 5,083 | $213.14 | Sell | $1,083,390.62 | |
| Feb. 4, 2021 | SVP | 18,097 | $178.50 | Sell | $3,230,314.50 | |
| Feb. 4, 2021 | COO | 44,547 | $176.86 | Sell | $7,878,582.42 | |
| Jan. 27, 2021 | CEO | 40,000 | $182.00 | Sell | $7,280,000.00 | |
| Jan. 25, 2021 | CEO | 50,000 | $159.00 | Sell | $7,950,000.00 | |
| Aug. 24, 2020 | COO | 78 | $110.89 | Sell | $8,649.42 | |
| Aug. 21, 2020 | COO | 7,225 | $112.88 | Sell | $815,558.00 | |
| June 4, 2020 | SVP | 11,146 | $118.59 | Sell | $1,321,804.14 | |
| Feb. 27, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 | |
| Feb. 27, 2020 | COO | 1,706 | $21.92 | Buy | $37,395.52 | |
| Feb. 27, 2020 | COO | 7,225 | $110.00 | Sell | $794,750.00 | |
| Feb. 15, 2020 | COO | 869 | $97.23 | Sell | $84,492.87 | |
| Feb. 15, 2020 | COO | 447 | $97.23 | Sell | $43,461.81 | |
| Feb. 15, 2020 | COO | 1,170 | $97.23 | Sell | $113,759.10 | |
| Feb. 14, 2020 | COO | 7,225 | $14.47 | Buy | $104,545.75 | |
| Feb. 14, 2020 | COO | 7,225 | $95.84 | Sell | $692,444.00 | |
| Feb. 13, 2020 | COO | 496 | $21.92 | Buy | $10,872.32 | |
| Feb. 13, 2020 | COO | 7,396 | $0.00 | Buy | $0.00 | |
| Sept. 3, 2019 | Director | 750 | $87.01 | Buy | $65,257.50 | |
| Aug. 5, 2019 | Director | 746 | $90.01 | Buy | $67,147.46 |
Insiders are both buying and selling Ligand Pharmaceuticals Incorporated stock.
The insider traders at Ligand Pharmaceuticals Incorporated are: Matthew W Foehr, John L Higgins, Jason Aryeh, John W Kozarich, Charles S Berkman, Matthew E Korenberg, Todd C Davis, Octavio Espinoza, Andrew Reardon, Bvf Partners L P/Il, John L Lamattina, Stephen L Sabba, David M Knott, Bvf Partners P/Il, Melanie J Herman, John Sharp, Matthew Foehr, David Knott, Nishan M Desilva, Charles Berkman, Sunil Patel, John Lamattina, Todd Davis, John W. Kozarich, Melanie J. Herman, and John Higgins
The most active insider trader at Ligand Pharmaceuticals Incorporated is Matthew W Foehr with 27 trades.
Bvf Partners P/Il has sold the most Ligand Pharmaceuticals Incorporated stock with a total value of $58,156,493.18.
Bvf Partners L P/Il has bought the most Ligand Pharmaceuticals Incorporated stock with a total value of $2,817,728.47.
The most recent insider trade for Ligand Pharmaceuticals Incorporated was on Nov. 27, 2024.
The single biggest insider buy for Ligand Pharmaceuticals Incorporated was from Bvf Partners L P/Il with a total value of $898,794.00 on Dec. 6, 2012.
The single biggest insider sell for Ligand Pharmaceuticals Incorporated was from Bvf Partners P/Il with a total value of $31,214,249.00 on Feb. 20, 2014.